Last week was pretty solid for IPOs. Nine new stocks pulled off their deals, raising about $2 billion or so. The standout performance was Virgin America (VA), which posted a gain of 30%.
But there was still some weakness with biotech deals. For example, the shares of NeuroDerm (NDRM) lost 8%, even though the offering was struck at the mid-point of the expected price range.